Skip to main content
Fig. 2 | BMC Bioinformatics

Fig. 2

From: The expression landscape of JAK1 and its potential as a biomarker for prognosis and immune infiltrates in NSCLC

Fig. 2

Kaplan–Meier survival curves comparing high and low expression of JAK1 in NSCLC. A, B OS and PFS survival curves of NSCLC (n = 1144, n = 596). C, D OS and PFS survival curves of LUAD (n = 672, n = 443). E, F OS and PFS survival curves of LUSC (n = 271, n = 141). OS overall survival, PFS progression-free survival, LUAD lung adenocarcinoma, LUSC lung squamous cell carcinoma, NSCLC non-small-cell lung cancer, HR hazard ratio

Back to article page

BMC Bioinformatics

ISSN: 1471-2105

Contact us